Atomwise, a well-connected player in the burgeoning space of artificial intelligence-powered drug discovery, cut its headcount by 30% in December, Endpoints News has learned.
Abraham Heifets CEO and co-founder Abraham Heifets confirmed the layoffs, which resulted in around 30 people departing the company.
“We had...
